Melanoma Recurrent
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS) (NCT07376317) | Instituto do Cancer do Estado de São Paulo | 2021-12-10 |
| A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors (NCT04478279) | Sapience Therapeutics | 2020-07-01 |
| Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma (NCT02574533) | Gradalis, Inc. | 2015-10-01 |
| Expanded Access for Pembrolizumab (MK-3475) (NCT03311542) | Center Trials & Treatment |
Track Melanoma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.